Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Matthias P Müller

Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination With Trametinib in KRAS-mutant Pancreatic and Colorectal Cancer

Cancer Research

Cancer Research

English

Related publications

Preclinical Activity of the Rational Combination of Selumetinib (AZD6244) in Combination With Vorinostat in KRAS-Mutant Colorectal Cancer Models

Clinical Cancer Research

Cancer Research

English

LY3009120, a panRAF Inhibitor, Has Significant Anti-Tumor Activity in BRAF and KRAS Mutant Preclinical Models of Colorectal Cancer

English

Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance.

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Preclinical Efficacy of the Novel Competitive NAMPT Inhibitor STF-118804 in Pancreatic Cancer

English

Combination PI3K/MEK Inhibition Promotes Tumor Apoptosis and Regression in PIK3CA Wild-Type, KRAS Mutant Colorectal Cancer

Cancer Research

English

Allosteric Inhibitors Target KRAS in a Mutant-Specific Manner

Cancer Discovery

English

Safety and Efficacy of the Addition of Simvastatin to Cetuximab in Previously Treated KRAS Mutant Metastatic Colorectal Cancer Patients

Investigational New Drugs

English

New Strategies for Treatment of KRAS Mutant Metastatic Colorectal Cancer

Clinical Cancer Research

Cancer Research

English

Trametinib With and Without Pazopanib Has Potent Preclinical Activity in Thyroid Cancer

Oncology Reports

Cancer Research

English